Abstract
Two possible dangers of an extensive varicella vaccination program are more varicella (chickenpox) cases in adults, when the complication rates are higher, and an increase in cases of zoster (shingles). Here an age-structured epidemiologic—demographic model with vaccination is developed for varicella and zoster. Parameters are estimated from epidemiological data. This mathematical and computer simulation model is used to evaluate the effects of varicella vaccination programs. Although the age distribution of varicella cases does shift in the simulations, this does not seem to be a danger because many of the adult cases occur after vaccine-induced immunity wanes, so they are mild varicella cases with fewer complications. In the simulations, zoster incidence increases in the first three decades after initiation of a vaccination program, because people who had varicella in childhood age without boosting, but then it decreases. Thus the simulations validate the second danger of more zoster cases.
Article PDF
Similar content being viewed by others
References
Allen, L. J. S. and D. B. Thrasher (1998). The effects of vaccination in an age-dependent model for varicella and herpes zoster. IEEE Trans. Autom. Control 43, 779–789.
Anderson, R. M. and R. M. May (1985a). Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes. J. Hyg. Camb. 94, 365–436.
Anderson, R. M. and R. M. May (1985b). Vaccination and herd immunity to infectious disease. Nature 318, 323–329.
Anderson, R. M. and R. M. May (1991). Infectious Diseases of Humans: Dynamics and Control, Oxford: Oxford University Press.
Arvin, A. M. and A. A. Gershon (1996). Live attenuated varicella vaccine. Ann. Rev. Microbiol. 50, 59–100.
Asano, Y., S. Suga, T. Yoshikawa, I. Kobayashi, T. Yazaki, M. Shibata, K. Tsuzuki and S. Ito (1994). Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine. Pediatrics 94, 524–526.
Benenson, A. S. (1995). Control of Communicable Diseases Manual, 16th edn, Washington, DC: American Public Health Association.
Bernstein, H. H., E. P. Rothstein and Pennridge Pediatric Associates (1993). Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics 92, 833–837.
Blower, S. M. and H. Dowlatabadi (1994). Sensitivity and uncertainty analysis of complex models of disease transmission: an HIV model, as an example. Int. Stat. Rev. 62, 229–243.
Brunell, P. A. (1991). Chickenpox—examining our options. N. Engl. J. Med. 325, 1577–1579.
Centers for Disease Control and Prevention (1997). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 45(No. RR-11), 35–40.
Centers for Disease Control and Prevention (1998a). National, state, and urban area vaccination coverage levels among children aged 19–35 months—United States, July 1996–June 1997. MMWR 47(No. 6), 108–115.
Centers for Disease Control and Prevention (1998b). Varicella related deaths among children—United States, 1995–1997. MMWR 47(No. 18), 365–368.
Centers for Disease Control and Prevention (1998c). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 47(No. RR-6), 1–26.
Centers for Disease Control and Prevention (1998d). Tetanus surveillance—United States, 1997. MMWR 47(No. SS-2), 1–13.
DeJong, M. C. M., O. Diekmann and J. A. P. Heesterbeek (1995). How does transmission depend on population size? in Epidemic Models: Their Structure and Relation to Data, D. Mollison (Ed.), Cambridge: Cambridge University Press, pp. 84–94.
Donahue, J. G. and J. E. Manson (1995). The incidence of herpes zoster. Arch. Int. Med. 155, 1605–1609.
Ferguson, N. M., R. M. Anderson and G. P. Garnett (1996). Mass vaccination to control chickenpox: the influence of zoster. Proc. Natl. Acad. Sci. USA 93, 7231–7235.
Garnett, G. P. and N. M. Ferguson (1996). Predicting the effect of varicella vaccine on subsequent cases of zoster and varicella. Rev. Med. Virol. 6, 151–161.
Garnett, G. P. and B. T. Grenfell (1992a). The epidemiology of varicella-zoster virus infections: a mathematical model. Epidemiol. Infect. 108, 495–511.
Garnett, G. P. and B. T. Grenfell (1992b). The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol. Infect. 108, 513–528.
Gershon, A. A. (1995). Varicella vaccine: its past, present and future. Pediatr. Infect. Dis. J. 14, 742–744.
Gershon, A. A., R. Racker, S. Steinberg, B. Topf-Olstein and L. M. Drusin (1976). Antibody to varicella-zoster virus in parturient women and their offspring during the first year of life. Pediatrics 58, 692–696.
Gershon, A. A., P. LaRussa, I. Hardy, S. Steinberg and S. Silverstein (1992). Varicella vaccine: the American experience. J. Infect. Dis. 166(Suppl. 1), S63–S68.
Gershon, A. A., P. LaRussa, S. Steinberg, N. Mervish, S. H. Lo and P. Meier (1996). The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox. J. Infect. Dis. 173, 450–453.
Grenfell, B. T. and R. M. Anderson (1985). The estimation of age related rates of infection from case notifications and serological data. J. Hyg. Camb. 95, 419–436.
Grenfell, B. T. and R. M. Anderson (1989). Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination. Proc. Roy. Soc. Lond. B 236, 213–252.
Guess, H. A., D. D. Broughton, L. J. Melton III and L. T. Kurland (1985). Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics 76, 512–517.
Guess, H. A., D. D. Broughton, L. J. Melton and L. T. Kurland (1986). Population-based studies of varicella complications. Pediatrics 78(Suppl.), 723–727.
Halloran, M. E., S. L. Cochi, T. A. Lieu, M. Wharton and L. Fehrs (1994). Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am. J. Epidemiol. 140, 81–104.
Hammerschlag, M. R., A. A. Gerson, S. P. Steinberg and L. D. Gelb (1989). Herpes zoster in an adult recipient of live attenuated varicella vaccine. J. Infect. Dis. 160, 535–537.
Hardy, I., A. E. Gershon, S. P. Steinberg, P. LaRussa and the Varicella Vaccine Collaborative Study Group (1991). The incidence of zoster after immunization with live atenuated varicella vaccine. N. Engl. J. Med. 325, 1545–1550.
Hethcote, H. W. (1978). An immunization model for a heterogeneous population. Theor. Pop. Biol. 14, 338–349.
Hethcote, H. W. (1996). Modeling heterogeneous mixing in infectious disease dynamics, in Models for Infectious Human Diseases, V. Isham and G. F. H. Medley (Eds), Cambridge: Cambridge University Press, pp. 215–238.
Hethcote, H. W. (1997). An age-structured model for pertussis transmission. Math. Biosci. 145, 89–136.
Hethcote, H. W., H. W. Stech and P. van den Driessche (1981). Periodicity and stability in epidemic models: a survey, in Differential Equations and Applications in Ecology, Epidemics and Population Problems, S. N. Busenberg and K. L. Cooke (Eds), New York: Academic Press, pp. 65–82.
Hethcote, H. W. and J. W. Van Ark (1987). Epidemiological models for heterogeneous populations: proportionate mixing, parameter estimation, and immunization programs. Math. Biosci. 84, 85–118.
Hethcote, H. W. and J. A. Yorke (1984). Gonorrhea Transmission Dynamics and Control, Lecture Notes in Biomathematics 56, Berlin: Springer-Verlag.
Hope-Simpson, R. E. (1965). The nature of herpes zoster: a long term study and a new hypothesis. Proc. Roy. Soc. Med. 58, 9–20.
Huse, D. M., H. C. Meissner, M. J. Lacey and G. Oster (1994). Childhood vaccination against chickenpox: an analysis of benefits and costs. J. Pediatrics 124, 869–874.
Izurieta, H. S., P. W. M. Strebel and P. A. Blake (1997). Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. JAMA 278, 1495–1499.
Krause, P. R. and D. M. Klinman (1995). Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine. J. Pediatrics 127, 518–525.
Kurtzke, J. F. (1982). The current neurologic burden of illness and injury in the United states. Neurology 32, 1207–1214.
Levin, M. J., M. Murray, G. O. Zerbe, C. J. White and A. R. Hayward (1994). Immune responses of elderly persons four years after receiving a live attenuated varicella vaccine. J. Infect. Dis. 170, 522–526.
Lieu, T. A., S. L. Cochio, S. B. Black, M. E. Halloran, H. R. Shinefeld, S. J. Holmes, M. Wharton and A. E. Washington (1994). Cost-effectiveness for a routine varicella vaccination program for US children. JAMA 271, 375–381.
McLean, A. R. and S. M. Blower (1993). Imperfect vaccines and herd immunity to HIV. Proc. Roy. Soc. Lond. B 253, 9–13.
Mena-Lorca, J. and H. W. Hethcote (1992). Dynamic models of infectious diseases as regulators of population sizes. J. Math. Biol. 30, 693–716.
Plotkin, S. (1994). Vaccines for varicella-zoster virus and cytolomegalovirus: recent progress. Science 265, 1383–1385.
Plotkin, S., S. E. Starr, K. Conner and D. Morton (1989). Zoster in normal children after varicella vaccine. J. Infect. Dis. 159, 1000–1001.
Preblud, S. R. (1981). Age specific risks of varicella complications. Pediatrics 68, 14–17.
Preblud, S. R., W. A. Orenstein, J. P. Kaplan, K. J. Bart and A. R. Hinman (1985). A benefit-cost analysis of a childhood varicella vaccination programme. Postgraduate Med. J. 61(Suppl. 4), 17–22.
Redbook (1977). Report of the Committee on Infectious Diseases, Eighteenth Edition, Evanston, IL: American Academy of Pediatrics.
Rouderfer, V., H. W. Hethcote and N. G. Becker (1993). Waning immunity and its effects on vaccination schedules. Math. Biosci. 124, 59–82.
U.S. Bureau of the Census (1994). Statistical Abstract of the United States, Washington, DC: Government Printing Office.
Watson, B. M., S. A. Piercy, S. A. Plotkin and S. E. Starr (1993). Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 91, 17–22.
Wharton, M. (1996). The epidemiology of varicella-zoster virus infections. Infect. Dis. Clinics N. Am. 10, 571–581.
Whitley, R. J. (1992). Therapeutic approaches to varicella-zoster virus infections. J. Infect. Dis. 166(Suppl. 1), S51–S57.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schuette, M.C., Hethcote, H.W. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull. Math. Biol. 61, 1031–1064 (1999). https://doi.org/10.1006/bulm.1999.0126
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1006/bulm.1999.0126